Juretzka Margrit M, Crawford Cimberly L, Lee Christine, Wilton Andrew, Schuman Samer, Chi Dennis S, Sonoda Yukio, Barakat Richard R, Abu-Rustum Nadeem R
Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Gynecol Oncol. 2006 May;101(2):327-30. doi: 10.1016/j.ygyno.2005.10.025. Epub 2005 Dec 19.
To describe the results of laparoscopic management of adnexal masses in women with a history of nongynecologic malignancy.
We conducted a retrospective review of 262 patients with history of prior nongynecologic malignancy who underwent laparoscopy for management of an adnexal mass between 1/1992 and 6/2004.
Median patient age at laparoscopy was 55 years (range, 20-91 years), and median BMI was 25 kg/m2 (range, 14-41 kg/m2). Of the 262 patients, 145 (55.3%) had prior abdominal/pelvic surgery. Prior cancer history included breast (202, 77.1%), lymphoma/leukemia (16, 6.1%), colorectal (8, 3.0%), lung (7, 2.7%), multiple myeloma (5, 1.9%), head/neck (5, 1.9%), genitourinary (5, 1.9%), upper gastrointestinal (4, 1.5%), and other (10, 3.8%). Median ovarian mass diameter measured on radiologic imaging was 3.8 cm (range, 0.2-13.5 cm); median CA-125 was 17.0 U/mL (range, 1-7000 U/mL). In all, 49 (18.7%) patients had malignancy identified at laparoscopy, with 30/49 (61.2%) diagnosed with metastatic malignancy to the ovary and 19/49 (38.8%) having a new primary ovarian malignancy. Median tumor diameter and CA-125 were significantly higher in women found to have a malignancy (4.7 vs. 3.7 cm, and 35 vs. 14 U/mL, respectively). Overall, conversion to laparotomy occurred in 34 (12.9%) cases. Twenty-one of 49 (42.9%) patients with malignancy were converted to laparotomy compared with 13/213 (6.1%) when benign disease was noted (P < 0.001).
Approximately 1 in 5 patients with a history of nongynecologic malignancy who were selected for laparoscopic management of an adnexal mass was found to have malignancy, with 60% being metastatic from other primaries. The majority of cases were managed laparoscopically even if malignancy was identified.
描述有非妇科恶性肿瘤病史的女性附件肿块的腹腔镜治疗结果。
我们对1992年1月至2004年6月期间因附件肿块接受腹腔镜检查的262例有非妇科恶性肿瘤病史的患者进行了回顾性研究。
腹腔镜检查时患者的中位年龄为55岁(范围20 - 91岁),中位体重指数为25 kg/m²(范围14 - 41 kg/m²)。262例患者中,145例(55.3%)曾接受过腹部/盆腔手术。既往癌症病史包括乳腺癌(202例,77.1%)、淋巴瘤/白血病(16例,6.1%)、结直肠癌(8例,3.0%)、肺癌(7例,2.7%)、多发性骨髓瘤(5例,1.9%)、头颈部癌(5例,1.9%)、泌尿生殖系统癌(5例,1.9%)、上消化道癌(4例,1.5%)以及其他癌症(10例,3.8%)。影像学检查测得的卵巢肿块中位直径为3.8 cm(范围0.2 - 13.5 cm);中位CA - 125为17.0 U/mL(范围1 - 7000 U/mL)。总共49例(18.7%)患者在腹腔镜检查时被确诊为恶性肿瘤,其中30/49例(61.2%)被诊断为卵巢转移性恶性肿瘤,19/49例(38.8%)为新发原发性卵巢恶性肿瘤。发现患有恶性肿瘤的女性的肿瘤中位直径和CA - 125显著更高(分别为4.7 cm对3.7 cm,35 U/mL对14 U/mL)。总体而言,34例(12.9%)病例中转开腹手术。49例恶性肿瘤患者中有21例(42.9%)转开腹手术,而发现为良性疾病时这一比例为13/213例(6.1%)(P < 0.001)。
在因附件肿块选择进行腹腔镜治疗的有非妇科恶性肿瘤病史的患者中,约五分之一被发现患有恶性肿瘤,其中60%为其他原发部位的转移瘤。即使确诊为恶性肿瘤,大多数病例仍通过腹腔镜进行治疗。